了解瘤微环境,用于早期发病的头部和部状细胞癌的个性化免疫疗法
Yidan Shan1, Di He1, Fengguo Yan1
1Department of Oral & Maxillofacial Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Frontiers in immunology
|January 20, 2025
概括
早期发作的头部和部状细胞癌 (HNSCC) 显示出更具攻击性的瘤微环境 (TME). 量身定制的免疫疗法可以改善年轻HNSCC患者的治疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 早期发病的头部和部状细胞癌 (HNSCC) 正在增加,与老年患者相比,其具有明显的特征.
- 年轻HNSCC患者的瘤微环境 (TME) 和潜在机制尚未完全理解.
研究的目的:
- 审查对年轻HNSCC患者的研究,重点关注TME特征.
- 探索早期HNSCC个性化免疫疗法的潜力.
主要方法:
- 对涉及年轻HNSCC患者样本的原始研究进行系统审查.
- 对TME特征和免疫特征的分析.
主要成果:
- 在早期出现的HNSCC中,TME通常会显示出增加的攻击性.
- 有证据表明,在年轻患者中,TME具有更强的免疫抑制作用.
结论:
- 早期出现的HNSCC呈现出一个独特的TME概况.
- 对这个人群来说,个性化免疫治疗策略可能是有益的.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Tumor Immunotherapy
468
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
468
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


